Fondation de France
OrganisationROR
Trials
Collaborator, Phase 4, Completed, 2,500 people, 22 Jan 2009
Funded papers
11 Sept 2026
00089829, 12 Aug 2026
5 Jan 2026
28 Oct 2025
00086320, 25 Sept 2025
Emerging strategies, applications and challenges of targeting NAD+ in the clinic
00147852 / WB-2023-51647, 9 Sept 2025
Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov